Alzheimers Disease is a huge market Gary with no cure on the immediate horizon:
alzheimers.com
Until recently, nothing seemed to slow the inexorable mental decline of people with Alzheimer's disease. But recently, as researchers have learned more about the development of Alzheimer's, several promising treatments have been identified, two have been approved, and many more are in development.
Treatment of Alzheimer's disease is still in its infancy, and experts are quick to concede that they have a long way to go. But today, for the first time, researchers have become cautiously optimistic that in the not-too-distant future, new treatments should be able to delay the onset Alzheimer's disease, and slow the mental deterioration it causes. Many predict that within the next decade or so, it will become a reasonably manageable chronic illness, rather like diabetes or asthma.
I would expect to see a round of upgrades issued from analysts about the same time phase I research begins for ELN on Alzheimer's Disease.
That should bring us a much higher stock price.
Investors are advised to do their own due diligence. Anything that I may state, in any post, is merely an opinion based on prior experiences and future expectations. I may have a long position in this stock and as such I am biased by my own expectations. I invest to make money. As always, I am looking for a big return to
Sender |
